On the 8th October our Scientific & Medical Manager, Dr Marta Carrera, attended as a key speaker at the Spanish Familial Hypercholesterolemia (FH) Foundation Conference presenting the “Utility of genetics in the clinical and therapeutic management of FH”.
Familial hypercholesterolemia (FH) is the most common genetic condition globally. FH causes high cholesterol and increases the risk of cardiovascular disease and heart attack. However, 90% of patients born with FH are undiagnosed.
The Fundación Hipercolesterolemia Familiar (FHF) is a Spanish nationwide organisation, created to raise awareness of genetic induced high cholesterol, and the need to promote early detection in families, as well as treatment and control to prevent cardiovascular mortality in people with Familial Hypercholesterolemia (FH).
The FHF results from the combined effort of patients and health care professionals giving their knowledge, support, commitment and dedication to raise FH awareness. The FHF relies on experts, both in Spain and internationally, to share information and to collaborate in research to translate scientific knowledge into a global response to FH diagnosis and treatment.
